NZ607593A - Heterocyclic compound and use thereof - Google Patents

Heterocyclic compound and use thereof

Info

Publication number
NZ607593A
NZ607593A NZ607593A NZ60759311A NZ607593A NZ 607593 A NZ607593 A NZ 607593A NZ 607593 A NZ607593 A NZ 607593A NZ 60759311 A NZ60759311 A NZ 60759311A NZ 607593 A NZ607593 A NZ 607593A
Authority
NZ
New Zealand
Prior art keywords
dihydropyrido
thiadiazine
dioxide
compound
heterocyclic compound
Prior art date
Application number
NZ607593A
Other languages
English (en)
Inventor
Ujikawa Osamu
Masakuni Kori
Shinji Nakamura
Masashi Toyofuku
Eiji Honda
Yasutomi Asano
Michiyo Mochizuki
Imaeda Toshihiro
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Publication of NZ607593A publication Critical patent/NZ607593A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
NZ607593A 2010-08-10 2011-08-09 Heterocyclic compound and use thereof NZ607593A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2010179577 2010-08-10
PCT/JP2011/068497 WO2012020848A1 (en) 2010-08-10 2011-08-09 Heterocyclic compound and use thereof

Publications (1)

Publication Number Publication Date
NZ607593A true NZ607593A (en) 2015-01-30

Family

ID=44534564

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ607593A NZ607593A (en) 2010-08-10 2011-08-09 Heterocyclic compound and use thereof

Country Status (39)

Country Link
US (11) US8575154B2 (enExample)
EP (1) EP2603513B1 (enExample)
JP (2) JP5788496B2 (enExample)
KR (1) KR101852215B1 (enExample)
CN (2) CN103180326B (enExample)
AR (1) AR082618A1 (enExample)
AU (1) AU2011290126B2 (enExample)
BR (1) BR112013002250B1 (enExample)
CA (1) CA2807460C (enExample)
CL (1) CL2013000380A1 (enExample)
CO (1) CO6680700A2 (enExample)
CR (1) CR20130066A (enExample)
CY (1) CY1123507T1 (enExample)
DK (1) DK2603513T3 (enExample)
DO (1) DOP2013000030A (enExample)
EA (1) EA022078B1 (enExample)
EC (1) ECSP13012478A (enExample)
ES (1) ES2793723T3 (enExample)
GE (1) GEP20156216B (enExample)
HR (1) HRP20200844T1 (enExample)
HU (1) HUE049460T2 (enExample)
IL (1) IL224452A (enExample)
LT (1) LT2603513T (enExample)
MA (1) MA34509B1 (enExample)
MX (1) MX349470B (enExample)
MY (1) MY165908A (enExample)
NZ (1) NZ607593A (enExample)
PE (1) PE20131116A1 (enExample)
PH (1) PH12013500247A1 (enExample)
PL (1) PL2603513T3 (enExample)
PT (1) PT2603513T (enExample)
RS (1) RS60311B1 (enExample)
SG (1) SG187656A1 (enExample)
SI (1) SI2603513T1 (enExample)
TW (1) TWI504604B (enExample)
UA (1) UA111594C2 (enExample)
UY (1) UY33551A (enExample)
WO (1) WO2012020848A1 (enExample)
ZA (1) ZA201301120B (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR082618A1 (es) * 2010-08-10 2012-12-19 Takeda Pharmaceutical Derivados de tiadiazina, composiciones farmaceuticas y usos
JP5976011B2 (ja) * 2011-04-05 2016-08-23 武田薬品工業株式会社 スルホンアミド誘導体およびその用途
EP2813508B1 (en) * 2012-02-08 2018-01-31 Takeda Pharmaceutical Company Limited Heterocyclic compound and use thereof
US20150011554A1 (en) * 2013-06-13 2015-01-08 Veroscience Llc Compositions and Methods for Treating Metabolic Disorders
TN2015000547A1 (fr) 2013-06-27 2017-04-06 Pfizer Composes heteroaromatiques et leur utilisation comme ligands de dopamine d1
US11589583B2 (en) 2013-12-03 2023-02-28 Fmc Corporation Pyrrolidinones herbicides
CA2931961C (en) 2013-12-03 2023-10-31 Andrew Duncan Satterfield Pyrrolidinones as herbicides
MX389921B (es) 2014-07-02 2025-03-20 Fmc Corp Star Herbicidas de piperidinona.
JP6611816B2 (ja) 2014-12-08 2019-11-27 エフ エム シー コーポレーション 3−オキソ−3−(アリールアミノ)プロパノエイト、その製造方法、およびピロリジノンの製造におけるその使用
AU2016246410B2 (en) 2015-04-10 2020-11-05 Fmc Corporation Substituted cyclic amides as herbicides
RU2734932C2 (ru) 2015-04-27 2020-10-26 ЭфЭмСи Корпорейшн Бутиролактоны в качестве гербицидов
HUE053943T2 (hu) 2015-04-29 2021-08-30 Janssen Pharmaceutica Nv Azabenzimidazolok és ampa receptor modulátorokként való alkalmazásuk
CN107567452B (zh) * 2015-04-29 2020-07-07 詹森药业有限公司 咪唑并哌嗪和吡唑并嘧啶以及它们作为ampa受体调节剂的用途
CA2980643C (en) 2015-05-12 2023-10-17 E I Du Pont De Nemours And Company Aryl substituted bicyclic compounds as herbicides
EP3303287B1 (en) 2015-05-29 2020-12-16 FMC Corporation Substituted cyclic amides as herbicides
JP6949730B2 (ja) 2015-06-02 2021-10-13 エフ エム シー コーポレーションFmc Corporation 置換環状アミドおよび除草剤としてのそれらの使用
RU2720994C2 (ru) 2015-07-31 2020-05-15 Е.И.Дюпон Де Немур Энд Компани Новые соединения циклического n-карбоксамида, применяемые в качестве гербицидов
SI3331892T1 (sl) * 2015-08-06 2019-10-30 Hoffmann La Roche Postopki za pripravo derivatov gaINAc kisline
US20170181292A1 (en) * 2015-12-16 2017-06-22 Rohm And Haas Electronic Materials Llc Method for forming organic coating on nickel surface
CN105669731B (zh) * 2016-01-10 2017-06-30 沧州普瑞东方科技有限公司 一种4‑(4‑烷基环己氧基)苯硼酸的合成方法
ES2958741T3 (es) 2016-12-21 2024-02-14 Fmc Corp Herbicidas de nitrona
CN107892697B (zh) 2016-12-26 2020-11-03 郑州泰基鸿诺医药股份有限公司 一种[1,3]噻嗪-2-胺类化合物及应用,药物组合物
UA126576C2 (uk) 2017-03-21 2022-11-02 ЕфЕмСі КОРПОРЕЙШН Гербіцидна суміш, композиція та спосіб
KR102620213B1 (ko) 2017-03-21 2024-01-03 에프엠씨 코포레이션 피롤리디논 및 이의 제조 방법
AR111839A1 (es) 2017-05-30 2019-08-21 Fmc Corp Lactamas 3-sustituidas herbicidas
AR111967A1 (es) 2017-05-30 2019-09-04 Fmc Corp Amidas herbicidas
WO2019070043A1 (ja) 2017-10-06 2019-04-11 武田薬品工業株式会社 複素環化合物
EP3693360B1 (en) * 2017-10-06 2023-12-13 Takeda Pharmaceutical Company Limited Heterocyclic compounds
US12370192B2 (en) 2019-09-16 2025-07-29 Takeda Pharmaceutical Company Limited Azole-fused pyridazin-3(2H)-one derivatives
TW202207944A (zh) * 2020-05-15 2022-03-01 日商武田藥品工業股份有限公司 抑鬱症之治療
CN113943294A (zh) * 2020-07-15 2022-01-18 成都海博为药业有限公司 一种作为btk抑制剂的化合物及其制备方法与用途
WO2025226581A1 (en) 2024-04-22 2025-10-30 Neurocrine Biosciences, Inc. Osavampator for use in the treatment of depressive disorders and cognitive impairment

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0437742Y2 (enExample) 1986-10-22 1992-09-04
JPH0285851A (ja) * 1988-09-22 1990-03-27 Konica Corp 新規な写真用カプラー
JPH037742A (ja) 1989-06-05 1991-01-14 Toyo Tire & Rubber Co Ltd ラバーチエーン用ゴム組成物
JP2874960B2 (ja) * 1990-06-03 1999-03-24 コニカ株式会社 新規な染料を含有するハロゲン化銀写真感光材料
JPH04119890A (ja) 1990-09-11 1992-04-21 Konica Corp ピラゾロチアジアジン系色素
JP3430375B2 (ja) 1993-11-12 2003-07-28 コニカ株式会社 感熱転写材料及び該材料に好適な色素
DE19704923A1 (de) 1997-02-10 1998-08-13 Hoechst Schering Agrevo Gmbh Klebstoffhaltige Schädlingsbekämpfungsmittel
EP1229786A1 (en) 1999-11-04 2002-08-14 Colorado State University Method and device for attracting insects
FR2801587B1 (fr) 1999-11-30 2002-01-11 Adir Nouveaux derives de benzothiadiazines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CA2458388A1 (en) 2001-10-10 2003-04-17 Neurosearch A/S Novel benzothiazine derivatives, their preparation and use
FR2833955B1 (fr) 2001-12-21 2004-01-30 Servier Lab Nouveaux derives de benzothiazine et de benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2854634B1 (fr) 2003-05-05 2005-07-08 Servier Lab Nouveaux derives de thiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2865474B1 (fr) 2004-01-26 2008-06-13 Servier Lab Nouveaux derives de benzothiazines fluorees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2879201B1 (fr) * 2004-12-10 2007-02-16 Servier Lab Nouveaux derives de benzothiazine et benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
AU2007262661A1 (en) 2006-06-23 2007-12-27 Nufarm Australia Limited Phenoxy alkanoate herbicidal composition and method of preparation and use
AU2007333247B2 (en) * 2006-12-11 2012-06-07 Eli Lilly And Company AMPA receptor potentiators
US20080167374A1 (en) 2007-01-09 2008-07-10 Loveland Products, Inc. Pesticide composition and method of use
CN101910178A (zh) 2007-11-05 2010-12-08 先灵公司 γ分泌酶调节剂
JP2011507910A (ja) * 2007-12-21 2011-03-10 ユニバーシティー オブ ロチェスター 真核生物の寿命を変更するための方法
JPWO2009119088A1 (ja) 2008-03-25 2011-07-21 武田薬品工業株式会社 複素環化合物
JP2009248543A (ja) * 2008-04-11 2009-10-29 Fujifilm Corp 光情報記録媒体および情報記録方法
TW201012803A (en) * 2008-06-06 2010-04-01 Organon Nv Heterocyclic derivatives
WO2010054078A1 (en) 2008-11-06 2010-05-14 Schering Corporation Gamma secretase modulators
TW201030002A (en) 2009-01-16 2010-08-16 Bristol Myers Squibb Co Bicyclic compounds for the reduction of beta-amyloid production
JP2012051806A (ja) 2009-02-26 2012-03-15 Eisai R & D Management Co Ltd イミダゾリルピラジン誘導体
FR2943342B1 (fr) 2009-03-20 2011-03-04 Servier Lab Nouveaux derives de benzothiadiazepines,leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
WO2010140339A1 (ja) 2009-06-01 2010-12-09 武田薬品工業株式会社 複素環化合物
CA2767764A1 (en) 2009-07-13 2011-01-20 Takeda Pharmaceutical Company Limited Heterocyclic compound and use thereof
WO2011036889A1 (ja) 2009-09-25 2011-03-31 武田薬品工業株式会社 複素環化合物
WO2011036885A1 (ja) 2009-09-25 2011-03-31 武田薬品工業株式会社 複素環化合物
AR082618A1 (es) * 2010-08-10 2012-12-19 Takeda Pharmaceutical Derivados de tiadiazina, composiciones farmaceuticas y usos

Also Published As

Publication number Publication date
AU2011290126A1 (en) 2013-03-07
BR112013002250B1 (pt) 2020-10-27
PE20131116A1 (es) 2013-10-24
US8575154B2 (en) 2013-11-05
HUE049460T2 (hu) 2020-09-28
LT2603513T (lt) 2020-05-25
KR20130138738A (ko) 2013-12-19
IL224452A (en) 2017-11-30
AU2011290126B2 (en) 2016-01-07
DK2603513T3 (da) 2020-06-15
US8778934B2 (en) 2014-07-15
EA022078B1 (ru) 2015-10-30
WO2012020848A1 (en) 2012-02-16
MA34509B1 (fr) 2013-09-02
CA2807460A1 (en) 2012-02-16
BR112013002250A2 (pt) 2016-05-24
US20170022222A1 (en) 2017-01-26
ES2793723T3 (es) 2020-11-16
CA2807460C (en) 2018-09-18
US9150591B2 (en) 2015-10-06
US20180162875A1 (en) 2018-06-14
US20200317692A1 (en) 2020-10-08
CN103180326B (zh) 2015-06-10
US9499568B2 (en) 2016-11-22
JP2016006080A (ja) 2016-01-14
EP2603513A1 (en) 2013-06-19
US11279713B2 (en) 2022-03-22
JP2013535408A (ja) 2013-09-12
JP6113789B2 (ja) 2017-04-12
SI2603513T1 (sl) 2020-07-31
UA111594C2 (uk) 2016-05-25
RS60311B1 (sr) 2020-07-31
US20140080817A1 (en) 2014-03-20
US20150073137A1 (en) 2015-03-12
PT2603513T (pt) 2020-06-08
EA201390222A1 (ru) 2013-08-30
CO6680700A2 (es) 2013-05-31
US8916551B2 (en) 2014-12-23
US9884875B2 (en) 2018-02-06
WO2012020848A8 (en) 2012-09-27
TW201217386A (en) 2012-05-01
MY165908A (en) 2018-05-18
AR082618A1 (es) 2012-12-19
KR101852215B1 (ko) 2018-04-25
CN104926837A (zh) 2015-09-23
ECSP13012478A (es) 2013-04-30
US20150353578A1 (en) 2015-12-10
US20130184266A1 (en) 2013-07-18
CN103180326A (zh) 2013-06-26
CR20130066A (es) 2013-05-03
US20130190291A1 (en) 2013-07-25
MX349470B (es) 2017-07-31
US20120077799A1 (en) 2012-03-29
JP5788496B2 (ja) 2015-09-30
UY33551A (es) 2012-03-30
CL2013000380A1 (es) 2013-05-31
US20240360156A1 (en) 2024-10-31
PL2603513T3 (pl) 2020-07-27
US20190263832A1 (en) 2019-08-29
CY1123507T1 (el) 2022-03-24
US10654874B2 (en) 2020-05-19
DOP2013000030A (es) 2013-03-15
PH12013500247A1 (en) 2013-03-11
SG187656A1 (en) 2013-03-28
TWI504604B (zh) 2015-10-21
HRP20200844T1 (hr) 2020-08-21
MX2013001614A (es) 2013-07-05
EP2603513B1 (en) 2020-03-11
ZA201301120B (en) 2014-04-30
GEP20156216B (en) 2015-01-12

Similar Documents

Publication Publication Date Title
NZ607593A (en) Heterocyclic compound and use thereof
WO2012137982A3 (en) Sulfonamide derivative and use thereof
JO3116B1 (ar) مشتق بيرازولوكينولين كمثبطات ل pde9
NZ601483A (en) Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
MX2015002511A (es) Compuestos de dihidropirimidina y su aplicacion en productos farmaceuticos.
MA33939B1 (fr) 5-alcynyl-pyrimidines
ECSP10010582A (es) Derivados de aminodihidrotiazina como inhibidores de bace para el tratamiento de la enfermedad de alzheimer
RU2711869C3 (ru) Имидазопирролопиразиновые производные, полезные для лечения заболеваний, вызванных аномальной активностью протеинкиназ Jak1, Jak3 или Syk
GEP201706620B (en) NOVEL 4-(SUBSTITUTED-AMINO)-7H-PYRROLO[2,3-d]PYRIMIDINES AS LRRK2 INHIBITORS
MX2014004479A (es) Derivados de oxazina novedosos y su uso en el tratamiento de enfermedades.
TW200736233A (en) Cyclohexyl piperazinyl methanone derivatives
NZ631258A (en) Nitrogenated heterocyclic compound
MX2014006026A (es) Derivados de aminopirimidina como moduladores de proteina cinasa 2 rica en unidades repetitivas de leucina (lrrk2).
IL235659A0 (en) History of 3, 4 - dihydro -2h - pyrido [1, 2 - a] pyrazine - 1,2,1] 6 converted diones used to treat (among others) Alzheimer's disease
MY155517A (en) Heterocyclic derivatives
CR20200286A (es) DERIVADOS DE DIHIDRO-BENZO-OXAZINA Y DIHIDRO-PIRIDO-OXAZINA (Divisional 2014-0294)
IN2012DN03182A (enExample)
TW200738651A (en) Cyclohexyl sulfonamide derivatives
PH12013500942A1 (en) Triazolopyridine compounds
MX346248B (es) Derivados de [1,2,3]triazol[4,5-d]pirimidina como agonistas de los agonistas del receptor canabinoide 2.
CA2801274C (en) Compounds for the treatment of clostridium difficile-associated disease
BR112012012458A2 (pt) novas formas polimórficas de metil {4,6-diamino-2-[1-(2-fluorobenzil)-1h-pirazolo [3,4-b] piridin-3-il] pirimidin-5-il} carbamato
HK1210162A1 (en) Pyrimidinone derivatives as antimalarial agents
ECSP11011053A (es) [4-(1-amino-etil)-ciclohexil]-metil-aminas como antibacterianos
GEP20146182B (en) Delta crystalline form of arginine salt of perindopril, process for its preparation, and pharmaceutical com¬po¬- sitions containing it

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 09 AUG 2016 BY BALDWINS INTELLECTUAL PROPERTY

Effective date: 20150619

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 09 AUG 2017 BY CPA GLOBAL

Effective date: 20160701

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 09 AUG 2018 BY CPA GLOBAL

Effective date: 20170629

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 09 AUG 2019 BY CPA GLOBAL

Effective date: 20180628

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 09 AUG 2020 BY CPA GLOBAL

Effective date: 20190628

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 09 AUG 2021 BY CPA GLOBAL

Effective date: 20200702

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 09 AUG 2022 BY COMPUTER PACKAGES INC

Effective date: 20210717

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 09 AUG 2023 BY COMPUTER PACKAGES INC

Effective date: 20220717

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 09 AUG 2024 BY COMPUTER PACKAGES INC

Effective date: 20230717

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 09 AUG 2025 BY COMPUTER PACKAGES INC

Effective date: 20240717

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 09 AUG 2026 BY COMPUTER PACKAGES INC

Effective date: 20250717